2022
DOI: 10.1097/bor.0000000000000902
|View full text |Cite
|
Sign up to set email alerts
|

Recent advances in the use of machine learning and artificial intelligence to improve diagnosis, predict flares, and enrich clinical trials in lupus

Abstract: Purpose of reviewMachine learning is a computational tool that is increasingly used for the analysis of medical data and has provided the promise of more personalized care. Recent findingsThe frequency with which machine learning analytics are reported in lupus research is comparable with that of rheumatoid arthritis and cancer, yet the clinical application of these computational tools has yet to be translated into better care. Considerable work has been applied to the development of machine learning models fo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 42 publications
0
1
0
Order By: Relevance
“…Thus far, considerable work in SLE has been focused on developing ML models to predict disease, diagnosis and prognosis. Other applications of AI in SLE including drug discovery, clinical trial design and interpretation, 171 diagnostic imaging analysis, personalised medicine and medical devices and technologies are just beginning. Increased availability and access to other types of data in the future will provide even more opportunities for SLE research.…”
Section: Future Considerationsmentioning
confidence: 99%
“…Thus far, considerable work in SLE has been focused on developing ML models to predict disease, diagnosis and prognosis. Other applications of AI in SLE including drug discovery, clinical trial design and interpretation, 171 diagnostic imaging analysis, personalised medicine and medical devices and technologies are just beginning. Increased availability and access to other types of data in the future will provide even more opportunities for SLE research.…”
Section: Future Considerationsmentioning
confidence: 99%